Michael H. Carrel: 2025 was an exceptional year at AtriCure, Inc. with achievements across our business. This trial is evaluating the benefit of our AtriClip devices on non-AFib patients undergoing ...
Vale slipped as weaker iron ore prices and uncertain demand from China cooled investor confidence, redirecting attention to how commodity swings could affect profits and future shareholder returns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results